7/24/2019 Medication Trolley
1/24
MEDICATION TROLLEY (WAD 2)
Bil Ubat Dos Indikasi Kontraindikasi1 Tab.
Acarbose
100mg
Initially 50 mg
daily, increase to
3 times daily upto 100 mg 3
times daily. Ma
!00 mg 3 times
daily
"on insulin
dependent diabetes
mellitus #"IDDM$%&en diet t&erapy is
insu'cient
"on insulin
dependent diabetes
mellitus #"IDDM$ in
combination %it&
eisting
con(entional oral
t&erapy %&ereglycaemic control is
inade)uate
*atients less t&an 1+
years, c&ronic intestinal
disorders associated%it& distinct
disturbances o
digestion and
absorption,
-onditions %&ic& may
deteriorate as a result o
increased intestinal gas
ormation, pregnancy,
lactation, se(ere renalimpairment
! Chloral
!"ra#e
$o"%&m
200g' ml
DU/ 0.5 2 1 g
#ma ! g$ %it&
plenty o %ater at
bedtime
*reoperati(e
sedation
ypersensiti(ity to
c&loral &ydrate products
-ardiac disease
epatic or renal
impairment
*regnancy 4breast
eeding
*orp&yria
astritis3 I* De+#rose
Ah!"ro&s
0, -'
ccording to t&e
needs o t&e
patient
6or parenteral
replenis&ment o
7uid and minimal
carbo&ydrate
calories as re)uired
by t&e clinical
condition o t&e
patient
*atients %it& anuria,
diabetic coma,
&yperglycaemia,
intracranial or
intraspinal
&aemorr&age, delirium
tremens in de&ydrated
patients and glucose2
galactose malabsorption
syndrome.
Do not administered
simultaneously %it&
blood t&roug& t&e same
inusion set because o
t&e possibility t&at
pseudoagglutination o
red cells may occur8 I* D%a/eam
10mg'2ml
9tatus
epilepticus, by
slo% I: 5210e(ery 10215
9tatus epilepticus
9keletal muscle
spasmniety disorders
;espiratory depression
cute pulmonary
insu'ciency9e(ere &epatic
7/24/2019 Medication Trolley
2/24
minute #rate not
more t&an 5
mg
7/24/2019 Medication Trolley
3/24
e(ery 328 &ours5 I*. D%go+%
0.mg' 2ml
;apid
digitilisation
DU/ 4 -I/D
o(er 10 years,
initially 0.?5 2 1.5mg, ollo%ed by
!50 mcg > &ourly
until digitilisation
is complete
eart ailure %it&
atrial @brillation
9upra(entricular
arr&yt&mias
#particularly atrial@brillation$
:entricular @brillation,
(entricular tac&ycardia
ecept in certain cases,
digitalis toicity, beriberi
&eart disease,&ypersensiti(ity to
digoin, some cases o
&ypersensiti(e carotid
sinus syndrome
> I*.
Dobam%e
20mg'2ml
Initial 0.521
mcg
7/24/2019 Medication Trolley
4/24
c&loride and
detrose inection
or 5C detrose I:
inusion,
ypertension o
pregnancyA !0mgper &our doubled
e(ery 30 min to
ma 1>0 mg per
&our I*
L%goca%e
100mg'ml
/ocal
anest&esia
DU/ Maimum
!00 mgA -I/D
Maimum 30
mg
7/24/2019 Medication Trolley
5/24
I:. Ma !00 F 300
mg< &our
-I/D 0.+ F 1
mg
&our and t&enollo%ed by an oral
9e(ere nausea and
(omiting
:ertigo < labyrint&ine
disorder
-"9 depression or coma
Bone marro% depression
*&aeoc&romocytoma
ypersensiti(ity to
p&enot&ia=ines
7/24/2019 Medication Trolley
6/24
dose.
"ot recommended in
c&ildren
-omatose states
-ardio(ascular collapse
1> Ra%#%"%e
0mg' 2ml
%*ec#%o
1$ DU/ slo% I:
inection o 50mg
diluted to !0ml andgi(en o(er at least
! minutes. Maybe
repeated e(ery >2+
&ours or I: inusion
at rate o !5
mg2+ &ours inter(als
or IM
-I/D 1mg &ours as re)uired
Ma 8 g daily
Use in c&ildren notrecommended
Mild to moderate
pain
astric and duodenal
ulcers
aemorr&agic diat&esis
ypersensiti(ity toaspirin or ot&er "9IDs
-&ildren under 1! years
old
ypersensiti(ity #attack
o ast&ma, angioedema,
urticaria or r&itinis$
*regnancy # t&ird
trimester$
*atient %it& &aemop&ilia
or &aemorr&agicdisorder
out
7/24/2019 Medication Trolley
7/24
9e(ere renal or &epatic
impairment
lactation1 !osc%e N
3!lbrom%"
e 10 mgTable# (B)
rade "ame
Buscopan
DU/ 102!0 mg 328
times daily.
-I/D >21! years
10 mg 3 times
daily
astrointestinal
tract and genito2
urinary tract spasm,dyskinesia o t&e
biliary system
Gbstructi(e disease o
t&e gastrointestinal or
urinary tract, narro%2angle glaucoma, cardiac
tac&yarr&yt&mias,
myast&enia gra(is,
prostatic &ypertrop&y
%it& urinary retention!0 Ib&ro7e
200 mg
Table# (B)
rade "ame
Bruen
DU/ !00 2 800
mg 3 times daily
ater ood,
maimum. !.8 g
daily -I/D !0230 mg
7/24/2019 Medication Trolley
8/24
!0 mgA -I/D less
t&an 15 years
0.1! mg
times a day beore
meals.
-I/D o(er > years
one tablet to be
taken 328 times a
day
eartburn,
dyspepsia
ypersensiti(ity to
antacids,
&ypop&osp&ataemia
!8 4rolase
Table#( B$
rade "ame
*apase
! tablet 8 times
daily
Gedema and
in7ammation in
conunction %it&
ot&er p&ysical or
c&emot&erapeutic
measures
Blood clotting disease.
!5 4rochlorera
/%e Malea#e
mg Table#
(B$rade "ame
9temetil
Inection IM 1!.5 mg
stat and repeated
i necessary ater >
&ours
or
orally !0 mg stat
ollo%ed by 10 mg
ater ! &ours.
*re(ention 5 2 10
mg ! 2 3 times a
day.
-I/D #o(er 10 kg
only$ !50 mcg
7/24/2019 Medication Trolley
9/24
se(eral %eeks to 5
2 10mg daily. "ot
recommended in
c&ildren
increased risk o
etrapyramidal
reactions
!> 4arace#amol00 mg
Table# (-$
rade "ame
*anadol
DU/ 500 2 1000mg e(ery 8 2 >
&ours, maimum o
8 g daily
Mild to moderatepain and pyreia
"ep&ropat&y
!? Tr%rol%"%e
Cl 2. mg
a"
4se&"oehe
"r%e Cl 80mg Table#
(B $
rade "ame
ctied
DU/ !.5 mg e(ery
8 2 > &oursA
maimum dose 10
mg 2 1! years
1.!5 mg e(ery 8 2
> &oursA maimum
dose 5 mg!5
mg e(ery 8 2 >
&oursA maimum
dose !.5 mg years 0.3+
mg e(ery 8 2 >
&oursA maimum
dose 3.?88
mg &oursA maimum
dose 1.!5 mg
7/24/2019 Medication Trolley
10/24
mg
7/24/2019 Medication Trolley
11/24
minutes beore
surgeryA
E/DE;/J 1 2 1.5
mg
7/24/2019 Medication Trolley
12/24
patients, 80mg
e(ery !8 &ours or
at least > days
until patient
ambulant, ma 18
days.reatment o D: or
pulmonary
embolism, 1.5
mg
7/24/2019 Medication Trolley
13/24
I patient needs to
undergo *-I,
unractionated
&eparin to be
admin as per local
practice protocol,taking into account
t&e patientOs
bleeding risk and
time o last dose o
ondaparinu.
6ondaparinu may
be restarted no
earlier t&an ! &r
ater s&eat&
remo(al. iii$ DU/ more t&an
1+ years !.5 mg
once dailyA @rst
dose to be gi(en I:
#directly t&roug&
an eisting I: line
or as inusion in !5
or 50 ml o 0.C
saline o(er 12!
min$, subse)uentdoses to be gi(en
9-. reatment to
be initiated as
soon as diagnosis
is made and
continued up to a
ma o + days or
until &ospital
disc&arge,
%&ic&e(er comesearlier. I patient
needs to undergo
non2primary *-I,
unractionated
&eparin to be
admin as per local
practice protocol,
taking into account
t&e patientOs
bleeding risk andtime o last dose o
segment ele(ation
myocardial inarction
#9EMI$ in patients
managed %it&
t&rombolytics or are
not recei(ing ot&erorms o reperusion
t&erapy
7/24/2019 Medication Trolley
14/24
ondaparinu.
6ondaparinu may
be restarted no
earlier t&an 3 &r
ater s&eat&
remo(al35 :l!cer!l
Tr%%#ra#e 0
mg'10 ml
I*ec#%o
;:l!cer!l
Tr%%#ra#e 2
mg' ml
I*ec#%o
Initial 5 mcg
7/24/2019 Medication Trolley
15/24
single 8 mg once
B* acceptability
&as been
demonstrated. 8
mg once daily or !
%eeks, may beincreased to + mg
once daily.
E/DE;/J ! mg once
daily or 1 %eek,
t&en 8 mg once
daily or t&e
ollo%ing %eek,
may be increased
up to + mg once
daily3 4o#ass%&m
Chlor%"e
($lo-
7/24/2019 Medication Trolley
16/24
e(ery > 2 + &ours
or as a single daily8! Ra%#%"%e
(=a#ac)
10mg Tab
150 mg t%ice daily
#at morning and
nig&t$ or 300 mg
on nig&t or 82+%eeks.
Maintenance 1502
300 mg on nig&t
150 mg t%ice daily
or 300 mg on nig&t
or +21! %eeks
150 mg daily or
t%ice daily
i($ 150 mg and may
be increased asnecessary to >
g
7/24/2019 Medication Trolley
17/24
&ours by 9-
inection.
s or unstable
angina and acute
perip&eral arterial
occlusion. *rop&ylais in
general surgery, by
9- inection, 5000
units ! &our beore
surgery, t&en
e(ery +21! &ours
or ? days or until
patient is
ambulant, during
pregnancy #%it&monitoring$, 50002
10000 units e(ery
1! &ours. n
adusted dose
regimen may be
used or maor
ort&opaedic
surgery or lo%
molecular %eig&t
&eparin may beselected
85 Wa#er 7or
I*ec#%o
ccording to t&e
needs o t&e
patient
s a diluent and
(e&icle or t&e
administration o
medications
"ot kno%n
8> Is&l%
Recomb%a
# $!#he#%c
&ma>
%#erme"%a#eac#%g 100
I?'ml 4e@ll
a" Re@ll 3
(Is&la#ar")
Dose to be
indi(idualised.
&e a(erage daily
insulin re)uirement
is bet%een 0.521.0units
7/24/2019 Medication Trolley
18/24
8? A&gme#%
1.2g I*
#moicillin
1g 4
-la(ulanate
!00mg In$(broad-
spectrum
anti-infective)
P 3 bln 30mg2+ &rly
Qangkitan
susceptible
organism pada
saluran respiratori,
kulit, tisu lembut,
U9epticaemia,
peritonitis,
osteomyelitis, post2
operati(e inection
ypersensiti(ity
ter&adap penicillin
9eara& penicillin2
associated c&olestatic
aundice
9eara& disungsi &epar
8+ 3e/!le%c%
ll% mega
&%#s (6g) I*
#narrow-
spectrum
anti-infective
*eads 50 F
100mg00 F
1!00mg IM )id, R?.!g daily in >
di(ided doses by
slo% I: inusion
Inecti(e
endocarditis
Qangkitan ole&
susceptible
organism
#Neisseriagonorrhoea, Corynebacterium
diphtheriae, Bacillus
anthracis, Clostridia,
Actinomycesbovis,S
treptobacillusmonili
formis, Listeriamon
ocytogenes,and Lept
ospiraA reponemap
allidum)
9eara& anap&ylais,
&ypersensiti(ity
ter&adap penicillin
8 Calc%&m:l&coa#e
10, I*
#Calcium)
*eads 50mg
7/24/2019 Medication Trolley
19/24
inter(als$
9urgical prop&ylais
1 g I: 0.5 F ! &r
prior procedure51 Ce7&ro+%me
so"%&m0mg I*
(broad-
spectrum
anti-infective)
*eads 30 F 100
mg
7/24/2019 Medication Trolley
20/24
3$55 9r&sem%"e
20mg'2ml %*
#"iuretic)
*eads 0.5 F
1.5mg am
Mera%at keradangan
#in7amasi$ seperti
dalam kes
o llergic reaction
o rt&ritis
o *enyakit
autoimmune#penyakit dara&,
kanser$o st&ma
2 1! years 10 ml 3
times daily. o be
taken %ell diluted
%it& %ater
6or systemic or urine
alkalinisation
9e(ere renal impairment
%it& oliguria, a=otemia
or anuria, ddisonOs
disease, adynamicepisodica &ereditaria,
acute de&ydration, &eat
cramps, se(ere
myocardial damage,
potassium citrate in
patients %it&
&yperkalemia, sodium
citrate or patients on
sodium restriction
>! Mages%&m
Tr%s%l%ca#e
102!0 ml 328 times eartburn,
dyspepsia
cute surgical abdomen,
&ypersensiti(ity to
7/24/2019 Medication Trolley
22/24
M%+#&re daily beore meals antacids,
&ypop&osp&ataemia
>3 Oral
Reh!"ra#%o
$al#
DU/ !00 2 800 ml
# 1 2 ! sac&ets $ or
e(ery loosemotion.
-I/D !00 ml #1
sac&et$ or e(ery
loose motion. In
se(ere de&ydration
100 ml8 4o#ass%&m
Chlor%"e 1
g'10 ml
I*ec#%o
By slo% I: inusion
depending on t&e
de@cit or t&e daily
maintenance
re)uirements. 1 g
diluted in 500 ml
normal saline or
glucose and gi(enslo%ly o(er ! 2 3
&ours
6or t&e correction o
se(ere
&ypokalaemia and
%&en su'cient
potassium cannot be
taken by mout&
cute de&ydration, &eat
cramps, &yperkalaemia,
renal ailure and in
conditions in %&ic&
potassium retention is
present or %&ere
additi(es o potassium
and c&loride could beclinically detrimental
>5 Lac#&lose6.6 g' mlL%B&%" B
rade "ame
Dup&alac
DU/ 15 ml t%ice
daily adusted to
patientOs need.
-I/D 0.5
ml
7/24/2019 Medication Trolley
23/24
EMER:ENCY TROLLEY (WAD 2)
Bi
l
Ubat
1 A"real%e 1mg'ml I*.! Am%oh!ll%e 20mg'
10ml I*.3 A#ro%e $&lha#e 1mg'ml
I*.8 Calc%&m :l&coa#e 1g'10
ml I*.5 Chlorhe%ram%e 10mg'ml
I*.> De+ame#hasoe5mg'2ml
I*.? De+#rose 0, -' I*+ D%go+% 0. mg'2ml I Dobam%e 20mg'20ml
I*.1
0
Doam%e 0mg'ml I*.
1
1
9l&ma/e%l 0.mg'ml I*.
1
!
9r&sem%"e 20mg'2ml I*.
13
:l!cer!l Tr%%#ra#e 0.mgTab.
1
8
:l!cer!l Tr%%#ra#e 0mg'
10ml I*.1
5
!"rocor#%soe 100mg I*.
1
>
Labe#alol 2mg'ml I*.
1
?
L%goca%e Cl 100mg'ml
I*.1
+
Nalo+oe Cl 0.mg'ml
(A"&l#) I*.1
Nora"real%e mg'ml I*.
!
0
4he!#o% $o"%&m
20mg'ml I*.!
1
4rome#ha/%e 0mg'2ml
I*.!
!
$o"%&m 3%carboa#e 5.,
I*.!
3
Terbal%e $&lha#e
2.mg'ml I*.! eraam%l mg'2ml I*.
7/24/2019 Medication Trolley
24/24
8!
5
Wa#er 7or I*ec#%o 10ml